Keyphrases
5-year Survival
20%
Acute Lymphoblastic Leukemia
80%
B-cell Lymphoproliferation
20%
Childhood Acute Lymphoblastic Leukemia
20%
Confidence Interval
80%
Cumulative Risk
20%
Diagnostic Test
20%
Early Diagnosis
20%
Epstein-Barr
20%
Etiology
20%
Hazard Ratio
20%
Hemophagocytic Lymphohistiocytosis
20%
Histopathological Features
20%
Immunodeficiency
60%
Immunodeficient
20%
Increased Mortality
20%
Leukaemia Trials
20%
Leukemia Diagnosis
20%
Leukemia Therapy
40%
Literature Search
20%
Lymphoid Leukemia
20%
Lymphoid Neoplasms
100%
Lymphoproliferation
20%
Maintenance Therapy
100%
Mature B Cells
20%
Mortality Hazard
20%
Non-Hodgkin Lymphoma
60%
Optimal Management Strategies
20%
Optimal Therapy
20%
Pediatric Acute Lymphoblastic Leukemia
100%
Post-acute
40%
Second Malignancy
40%
Second Neoplasm
20%
Stem Cell Transplantation
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Awareness
12%
B Cell
12%
Diagnostic Test
12%
Early Diagnosis
12%
Epstein Barr Virus
100%
Hazard Ratio
12%
Hemophagocytic Syndrome
12%
Immune Deficiency
37%
Leukemia
25%
Lymphocyte Proliferation
25%
Maintenance Therapy
100%
Neoplasm
100%
Non-Hodgkin Lymphoma
37%
Overall Survival
12%
Pediatrics
100%
Second Cancer
25%
Stem Cell Therapy
12%
Immunology and Microbiology
Awareness
33%
B Cell
33%
Epstein Barr Virus
100%
Hemophagocytic Lymphohistiocytosis
33%
Immunodeficiency
100%
Lymphocyte Proliferation
66%
Overall Survival
33%
Stem Cell Transplantation
33%